Table 2 Primary parameter: RQLQ global score

From: Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)

Parameter Groups V1 V3 V3−V1 variation
RQLQ global score Placebo 3.25 (0.91) 1.65 (1.24)# −1.61 (1.31)
  LP-33 3.25 (0.85) 1.40 (0.98)# −1.89 (1.22)
  P (ANOVA) NS 0.046 0.0255
  1. Abbreviations: ANOVA, analysis of variance; NS, not significant; RQLQ, rhinitis quality of life.
  2. Values are means (s.d.).
  3. Within-group comparisons between V3 and V1, #P<0.0001.
  4. Between-group comparison on V3−V1 variation, P<0.05.